Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Sodium Carbonate | HCID 10340 | — |
| Edukt | 1,4-Dioxane | HCID 31275 | — |
| Edukt | 4-Chloro-1,5-naphthyridine | HCID 596262 | — |
| Edukt | n-[2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]-4-fluorobenzene-1-sulfonamide | HCID 53363355 | — |
| Katalysator | HCID 178418397 | HCID 178418397 | — |
| Lösungsmittel | Water | HCID 962 | — |
| Produkt | HCID 44610007 | HCID 44610007 | 46% |
Reaktionsschritte
(Some starting materials may be obtained from Aldrich, St. Louis, Mo.) To a 50 mL round-bottomed flask was added 4-chloro-1,5-naphthyridine (40 mg, 243 μmol), N-(2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide (100 mg, 243 μmol), tetrakis(triphenylphosphine)palladium (28 mg, 24 μmol), sodium carbonate (243 μl, 486 μmol), dioxane (2 mL). The reaction mixture was stirred at 100° C. for 5 h. The mixture was cooled down to room temperature. The reaction mixture was diluted with water (3 mL) and extracted with EtOAc (2×30 mL). The organic extract was washed with saturated NaCl (3 mL), dried over Na2SO4, filtered and concentrated in vacuo and the residue was purified by silica gel chromatography, eluting with 70% EtOAc/hexanes to give N-(2-chloro-5-(1,5-naphthyridin-4-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide (46 mg, 46% yield) as a white solid. MS (ESI pos. ion) m/z calc'd for C19H12ClFN4O2S: 414.0; found 415.0. 1H NMR (300 MHz, CHLOROFORM-d) δ ppm 7.09 (s, 1 H) 7.13-7.23 (m, J=8.33 Hz, 2 H) 7.68 (d, J=4.38 Hz, 1 H) 7.75 (dd, J=8.55, 4.17 Hz, 1 H) 7.97 (dd, J=8.99, 4.90 Hz, 2 H) 8.49-8.56 (m, J=2.85, 2.85 Hz, 2 H) 8.58 (d, J=2.05 Hz, 1 H) 9.01 (dd, J=4.17, 1.68 Hz, 1 H) 9.10 (d, J=4.38 Hz, 1 H)
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US08415376B2 |
|---|
| Quelldatensatz | uspto-grants-2013_04 |
|---|
| ORD ID | ord-a6ad25e0f1b641ada53766f596d25e93 |
|---|
| Quellennotiz | uspto-grants-2013_04 |
|---|